Top-News
Gesundheitswesen: Anbieter u. Dienstleister USA

Immunovant News

Aktie
WKN:  A2P5G1 ISIN:  US45258J1025 US-Symbol:  IMVT
29,09 $
-0,60 $
-2,02%
20:28:18 Uhr
Handeln Depot/Watchlist
Aktienanzahl *
130,67 Mio.
Marktkapitalisierung *
3,60 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 27.09.2023

Immunovant News

21.12.23 - PR Newswire
Thinking about trading options or stock in Zai Lab, Visa, Crowdstrike, Bristol-Myers Squibb, or Immunovant?
Thinking about trading options or stock in Zai Lab, Visa, Crowdstrike, Bristol-​Myers Squibb, or Immunovant? PR Newswire
13.10.23 - PR Newswire
Thinking about trading options or stock in Dollar General, Immunovant, Camber Energy, Advanced Micro Devices, or Novo Nordisk?
Thinking about trading options or stock in Dollar General, Immunovant, Camber Energy, Advanced Micro Devices, or Novo Nordisk? PR Newswire
28.09.23 - PR Newswire
Thinking about buying stock in Seelos Therapeutics, West Red Lake Gold Mines, Immunovant, MSP Recovery, or Transcode Therapeutics?
Thinking about buying stock in Seelos Therapeutics, West Red Lake Gold Mines, Immunovant, MSP Recovery, or Transcode Therapeutics? PR Newswire
27.09.23 - PR Newswire
Thinking about buying stock in American Lithium, Avalo Therapeutics, Seelos Therapeutics, Rivian Automotive, or Immunovant?
Thinking about buying stock in American Lithium, Avalo Therapeutics, Seelos Therapeutics, Rivian Automotive, or Immunovant? PR Newswire
26.09.23 - PR Newswire
Thinking about trading options or stock in Immunovant, Manchester United, Philip Morris International, Vale SA, or Novo Nordisk?
Thinking about trading options or stock in Immunovant, Manchester United, Philip Morris International, Vale SA, or Novo Nordisk? PR Newswire
20.09.23 - PR Newswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Immunovant, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Immunovant, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors PR Newswire
23.05.23 - PR Newswire
Thinking about buying stock in Lucid, Immunovant, Arcellx, Vista Energy, or Terns Pharmaceuticals?
Thinking about buying stock in Lucid, Immunovant, Arcellx, Vista Energy, or Terns Pharmaceuticals? PR Newswire
05.10.22 - PR Newswire
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing PR Newswire
05.10.22 - PR Newswire
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing
R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing PR Newswire
20.04.21 - PR Newswire
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to ...
19.04.21 - PR Newswire
APRIL 20, 2021, IMVT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.
APRIL 20, 2021, IMVT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ...
01.04.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class ...
31.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class ...
29.03.21 - PR Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important April 20 Deadline - IMVT, HSACU, HSAC, HSACW
ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important April 20 Deadline - ...
24.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class ...
18.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class ...
18.03.21 - PR Newswire
IMVT SHAREHOLDER LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Immunovant, Inc.
IMVT SHAREHOLDER LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ...
17.03.21 - PR Newswire
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of ...
12.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline - IMVT; HSACU; HSAC; and HSACW
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class ...
08.03.21 - PR Newswire
IMVT BREAKING NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - IMVT, HSACU, HSAC, HSACW
IMVT BREAKING NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors with Losses in Excess ...

Newssuche

Videos

newspaper
13:20 Uhr +43,15%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »